The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy
Open accessAbstract
Glioblastoma (GBM) is the most aggressive tumor in the central nervous system and contains a highly immunosuppressive tumor microenvironment (TME). Tumor-associated macrophages and microglia (TAMs) are a dominant population of immune cells in the GBM TME that contribute to most GBM hallmarks, including immunosuppression. The understanding of TAMs in GBM has been limited by the lack of powerful tools to characterize them. However, recent progress on single-cell technologies offers an opportunity to precisely characterize TAMs at the single-cell level and identify new TAM subpopulations with specific tumor-modulatory functions in GBM. In this Review, we discuss TAM heterogeneity and plasticity in the TME and summarize current TAM-targeted therapeutic potential in GBM. We anticipate that the use of single-cell technologies followed by functional studies will accelerate the development of novel and effective TAM-targeted therapeutics for GBM patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Self-citationMacrophage plasticity, polarization, and function in health and disease
Shapouri‐Moghaddam, A., Mohammadian, S., Vazini, H., Taghadosi, M., Esmaeili, S., Mardani, F., Seifi, B., Mohammadi, A., Afshari, J. T., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26429 · Cited by 4,930
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · cited 2×
“, CD163 and CD206) have been identified in an attempt to distinguish the M1/M2 phenotype in TAMs (54, 55), specific markers for M1 or M2 macrophages are still missing (46, 56).”
BackgroundTumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Neftel, C., Laffy, J., Filbin, M. G., Hara, T., Shore, M. E., Rahme, G. J., Richman, A. R., Silverbush, D., Shaw, M. L., Hebert, C. M., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.024 · Cited by 2,873
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
Sharma, P., & Allison, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.03.030 · Cited by 2,345
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210
Wang, Q., Hu, B., Hu, X., Kim, H., Squatrito, M., Scarpace, L., deCarvalho, A. C., Lyu, S., Li, P., Li, Y., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.003 · Cited by 1,995
Self-citationA Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Sanmamed, M. F., & Chen, L. (2018) · Cell · doi:10.1016/j.cell.2018.09.035 · Cited by 1,392
Eleven grand challenges in single-cell data science
Lähnemann, D., Köster, J., Szczurek, E., McCarthy, D. J., Hicks, S. C., Robinson, M. D., Vallejos, C. A., Campbell, K. R., Beerenwinkel, N., Mahfouz, A., et al. (2020) · Genome Biology · doi:10.1186/s13059-020-1926-6 · Cited by 1,327
Challenges in unsupervised clustering of single-cell RNA-seq data
Kiselev, V. Y., Andrews, T. S., & Hemberg, M. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0088-9 · Cited by 1,160
Van Hove, H., Martens, L., Scheyltjens, I., De Vlaminck, K., Pombo Antunes, A. R., De Prijck, S., Vandamme, N., De Schepper, S., Van Isterdael, G., Scott, C. L., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0393-4 · Cited by 1,074
Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics
Longo, S. K., Guo, M. G., Ji, A. L., & Khavari, P. A. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00370-8 · Cited by 1,059
Klemm, F., Maas, R. R., Bowman, R. L., Kornete, M., Soukup, K., Nassiri, S., Brouland, J.-P., Iacobuzio-Donahue, C. A., Brennan, C., Tabar, V., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.007 · Cited by 1,037
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Zhao, J., Chen, A. X., Gartrell, R. D., Silverman, A. M., Aparicio, L., Chu, T., Bordbar, D., Shan, D., Samanamud, J., Mahajan, A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0349-y · Cited by 903 · cited 1×
“Emerging evidence reveals that GBM does not respond to immunotherapy, likely owing, at least in part, to the infiltration of immunosuppressive TAMs (62– 64).”
BackgroundClinical relevance of tumour-associated macrophages
Pittet, M. J., Michielin, O., & Migliorini, D. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00620-6 · Cited by 731
Pombo Antunes, A. R., Scheyltjens, I., Lodi, F., Messiaen, J., Antoranz, A., Duerinck, J., Kancheva, D., Martens, L., De Vlaminck, K., Van Hove, H., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00789-y · Cited by 704
Denisenko, E., Guo, B. B., Jones, M., Hou, R., de Kock, L., Lassmann, T., Poppe, D., Clément, O., Simmons, R. K., Lister, R., et al. (2020) · Genome Biology · doi:10.1186/s13059-020-02048-6 · Cited by 686
Denisenko, E., Guo, B. B., Jones, M., Hou, R., de Kock, L., Lassmann, T., Poppe, D., Clement, O., Simmons, R. K., Lister, R., et al. (2019) · doi:10.1101/832444 · Cited by 686
Friebel, E., Kapolou, K., Unger, S., Núñez, N. G., Utz, S., Rushing, E. J., Regli, L., Weller, M., Greter, M., Tugues, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.055 · Cited by 685
Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma
Chen, Z., Feng, X., Herting, C. J., Garcia, V. A., Nie, K., Pong, W. W., Rasmussen, R., Dwivedi, B., Seby, S., Wolf, S. A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2310 · Cited by 675
The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
Quail, D. F., Bowman, R. L., Akkari, L., Quick, M. L., Schuhmacher, A. J., Huse, J. T., Holland, E. C., Sutton, J. C., & Joyce, J. A. (2016) · Science · doi:10.1126/science.aad3018 · Cited by 666
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma
Ravi, V. M., Will, P., Kueckelhaus, J., Sun, N., Joseph, K., Salié, H., Vollmer, L., Kuliesiute, U., von Ehr, J., Benotmane, J. K., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.05.009 · Cited by 663
Müller, S., Kohanbash, G., Liu, S. J., Alvarado, B., Carrera, D., Bhaduri, A., Watchmaker, P. B., Yagnik, G., Di Lullo, E., Malatesta, M., et al. (2017) · Genome Biology · doi:10.1186/s13059-017-1362-4 · Cited by 654
Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies
Bowman, R. L., Klemm, F., Akkari, L., Pyonteck, S. M., Sevenich, L., Quail, D. F., Dhara, S., Simpson, K., Gardner, E. E., Iacobuzio-Donahue, C. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.052 · Cited by 619
Chu, T., Wang, Z., Pe’er, D., & Danko, C. G. (2022) · Nature Cancer · doi:10.1038/s43018-022-00356-3 · Cited by 603
Sikic, B. I., Lakhani, N., Patnaik, A., Shah, S. A., Chandana, S. R., Rasco, D., Colevas, A. D., O’Rourke, T., Narayanan, S., Papadopoulos, K., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02018 · Cited by 599
Butowski, N., Colman, H., De Groot, J. F., Omuro, A. M., Nayak, L., Wen, P. Y., Cloughesy, T. F., Marimuthu, A., Haidar, S., Perry, A., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov245 · Cited by 593
Hara, T., Chanoch-Myers, R., Mathewson, N. D., Myskiw, C., Atta, L., Bussema, L., Eichhorn, S. W., Greenwald, A. C., Kinker, G. S., Rodman, C., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.05.002 · Cited by 593
Emerging insights into the molecular and cellular basis of glioblastoma
Dunn, G. P., Rinne, M. L., Wykosky, J., Genovese, G., Quayle, S. N., Dunn, I. F., Agarwalla, P. K., Chheda, M. G., Campos, B., Wang, A., et al. (2012) · Genes & Development · doi:10.1101/gad.187922.112 · Cited by 565
Role of macrophages in Wallerian degeneration and axonal regeneration after peripheral nerve injury
Chen, P., Piao, X., & Bonaldo, P. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1482-4 · Cited by 520
Self-citationControl of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39
Takenaka, M. C., Gabriely, G., Rothhammer, V., Mascanfroni, I. D., Wheeler, M. A., Chao, C.-C., Gutiérrez-Vázquez, C., Kenison, J., Tjon, E. C., Barroso, A., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0370-y · Cited by 517 · cited 3×
“Inhibition of AHR with the antagonist CH-223191 suppresses CCL2-induced TAM infiltration and tumor growth (66).”
BackgroundSingle-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages
Ochocka, N., Segit, P., Walentynowicz, K. A., Wojnicki, K., Cyranowski, S., Swatler, J., Mieczkowski, J., & Kaminska, B. (2021) · Nature Communications · doi:10.1038/s41467-021-21407-w · Cited by 471
Deciphering human macrophage development at single-cell resolution
Bian, Z., Gong, Y., Huang, T., Lee, C. Z. W., Bian, L., Bai, Z., Shi, H., Zeng, Y., Liu, C., He, J., et al. (2020) · Nature · doi:10.1038/s41586-020-2316-7 · Cited by 467
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target
Abdelfattah, N., Kumar, P., Wang, C., Leu, J.-S., Flynn, W. F., Gao, R., Baskin, D. S., Pichumani, K., Ijare, O. B., Wood, S. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28372-y · Cited by 465
Mapping microglia states in the human brain through the integration of high-dimensional techniques
Sankowski, R., Böttcher, C., Masuda, T., Geirsdottir, L., Sagar, Sindram, E., Seredenina, T., Muhs, A., Scheiwe, C., Shah, M. J., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0532-y · Cited by 449
Gholamin, S., Mitra, S. S., Feroze, A. H., Liu, J., Kahn, S. A., Zhang, M., Esparza, R., Richard, C., Ramaswamy, V., Remke, M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2968 · Cited by 426
Perrot, I., Michaud, H.-A., Giraudon-Paoli, M., Augier, S., Docquier, A., Gros, L., Courtois, R., Déjou, C., Jecko, D., Becquart, O., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.091 · Cited by 423
Pienta, K. J., Machiels, J.-P., Schrijvers, D., Alekseev, B., Shkolnik, M., Crabb, S. J., Li, S., Seetharam, S., Puchalski, T. A., Takimoto, C., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9869-8 · Cited by 412
Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma
Qazi, M. A., Vora, P., Venugopal, C., Sidhu, S. S., Moffat, J., Swanton, C., & Singh, S. K. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx169 · Cited by 408
Wei, J., Marisetty, A., Schrand, B., Gabrusiewicz, K., Hashimoto, Y., Ott, M., Grami, Z., Kong, L.-Y., Ling, X., Caruso, H., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121266 · Cited by 396
Self-citationGangoso, E., Southgate, B., Bradley, L., Rus, S., Galvez-Cancino, F., McGivern, N., Güç, E., Kapourani, C.-A., Byron, A., Ferguson, K. M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.023 · Cited by 359
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma
Goswami, S., Walle, T., Cornish, A. E., Basu, S., Anandhan, S., Fernandez, I., Vence, L., Blando, J., Zhao, H., Yadav, S. S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-019-0694-x · Cited by 356
Ravi, V. M., Neidert, N., Will, P., Joseph, K., Maier, J. P., Kückelhaus, J., Vollmer, L., Goeldner, J. M., Behringer, S. P., Scherer, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28523-1 · Cited by 343
Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma
Chen, P., Zhao, D., Li, J., Liang, X., Li, J., Chang, A., Henry, V. K., Lan, Z., Spring, D. J., Rao, G., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.05.003 · Cited by 339
Self-citationFlores-Toro, J. A., Luo, D., Gopinath, A., Sarkisian, M. R., Campbell, J. J., Charo, I. F., Singh, R., Schall, T. J., Datta, M., Jain, R. K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1910856117 · Cited by 334
The triumphs and limitations of computational methods for scRNA-seq
Kharchenko, P. V. (2021) · Nature Methods · doi:10.1038/s41592-021-01171-x · Cited by 321
Akkari, L., Bowman, R. L., Tessier, J., Klemm, F., Handgraaf, S. M., de Groot, M., Quail, D. F., Tillard, L., Gadiot, J., Huse, J. T., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw7843 · Cited by 320
Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression
Yeo, A. T., Rawal, S., Delcuze, B., Christofides, A., Atayde, A., Strauss, L., Balaj, L., Rogers, V. A., Uhlmann, E. J., Varma, H., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01215-0 · Cited by 290
Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α
Wang, Q., He, Z., Huang, M., Liu, T., Wang, Y., Xu, H., Duan, H., Ma, P., Zhang, L., Zamvil, S. S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03050-0 · Cited by 277
Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion
Jiang, N., Xie, B., Xiao, W., Fan, M., Xu, S., Duan, Y., Hamsafar, Y., Evans, A. C., Huang, J., Zhou, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29137-3 · Cited by 258
Cancer Stemness Meets Immunity: From Mechanism to Therapy
Chen, P., Hsu, W.-H., Han, J., Xia, Y., & DePinho, R. A. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108597 · Cited by 252
Self-citationMicroglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma
Hutter, G., Theruvath, J., Graef, C. M., Zhang, M., Schoen, M. K., Manz, E. M., Bennett, M. L., Olson, A., Azad, T. D., Sinha, R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721434116 · Cited by 249
von Roemeling, C. A., Wang, Y., Qie, Y., Yuan, H., Zhao, H., Liu, X., Yang, Z., Yang, M., Deng, W., Bruno, K. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15129-8 · Cited by 242
Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas
Doucette, T., Rao, G., Rao, A., Shen, L., Aldape, K., Wei, J., Dziurzynski, K., Gilbert, M., & Heimberger, A. B. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0028 · Cited by 226
Self-citationTryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas
Friedrich, M., Sankowski, R., Bunse, L., Kilian, M., Green, E., Ramallo Guevara, C., Pusch, S., Poschet, G., Sanghvi, K., Hahn, M., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00201-z · Cited by 226
Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
Da Ros, M., De Gregorio, V., Iorio, A. L., Giunti, L., Guidi, M., De Martino, M., Genitori, L., & Sardi, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102879 · Cited by 223
Circadian Regulator CLOCK Recruits Immune-Suppressive Microglia into the GBM Tumor Microenvironment
Chen, P., Hsu, W.-H., Chang, A., Tan, Z., Lan, Z., Zhou, A., Spring, D. J., Lang, F. F., Wang, Y. A., & DePinho, R. A. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0400 · Cited by 215
Self-citationImmune landscapes associated with different glioblastoma molecular subtypes
Martinez-Lage, M., Lynch, T. M., Bi, Y., Cocito, C., Way, G. P., Pal, S., Haller, J., Yan, R. E., Ziober, A., Nguyen, A., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0803-6 · Cited by 211
Müller, A., Brandenburg, S., Turkowski, K., Müller, S., & Vajkoczy, P. (2015) · International Journal of Cancer · doi:10.1002/ijc.29379 · Cited by 185
Haage, V., Semtner, M., Vidal, R. O., Hernandez, D. P., Pong, W. W., Chen, Z., Hambardzumyan, D., Magrini, V., Ly, A., Walker, J., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0665-y · Cited by 173
de Groot, J., Penas-Prado, M., Alfaro-Munoz, K., Hunter, K., Pei, B. L., O’Brien, B., Weathers, S.-P., Loghin, M., Kamiya Matsouka, C., Yung, W. K. A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noz185 · Cited by 170
Self-citationSynergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40
Yang, F., He, Z., Duan, H., Zhang, D., Li, J., Yang, H., Dorsey, J. F., Zou, W., Nabavizadeh, S. A., Bagley, S. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23832-3 · Cited by 166
Cui, X., Ma, C., Vasudevaraja, V., Serrano, J., Tong, J., Peng, Y., Delorenzo, M., Shen, G., Frenster, J., Morales, R.-T. T., et al. (2020) · eLife · doi:10.7554/elife.52253 · Cited by 163
Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
Aslan, K., Turco, V., Blobner, J., Sonner, J. K., Liuzzi, A. R., Núñez, N. G., De Feo, D., Kickingereder, P., Fischer, M., Green, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14642-0 · Cited by 162
Targeting tumor-associated macrophages as an antitumor strategy
Cheng, N., Bai, X., Shu, Y., Ahmad, O., & Shen, P. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114354 · Cited by 161
Khalsa, J. K., Cheng, N., Keegan, J., Chaudry, A., Driver, J., Bi, W. L., Lederer, J., & Shah, K. (2020) · Nature Communications · doi:10.1038/s41467-020-17704-5 · Cited by 158
Macrophages are metabolically heterogeneous within the tumor microenvironment
Geeraerts, X., Fernández-García, J., Hartmann, F. J., de Goede, K. E., Martens, L., Elkrim, Y., Debraekeleer, A., Stijlemans, B., Vandekeere, A., Rinaldi, G., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110171 · Cited by 158
Pro-inflammatory and proliferative microglia drive progression of glioblastoma
Liu, H., Sun, Y., Zhang, Q., Jin, W., Gordon, R. E., Zhang, Y., Wang, J., Sun, C., Wang, Z., Qi, X., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109718 · Cited by 151
Yin, J., Kim, S. S., Choi, E., Oh, Y. T., Lin, W., Kim, T. H., Sa, J. K., Hong, J. H., Park, S., Kwon, H. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16789-2 · Cited by 150
Context-Dependent Glioblastoma–Macrophage/Microglia Symbiosis and Associated Mechanisms
Xuan, W., Lesniak, M. S., James, C. D., Heimberger, A. B., & Chen, P. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.02.004 · Cited by 149
Self-citationWang, X., Ding, H., Li, Z., Peng, Y., Tan, H. F., Wang, C., Huang, G., Li, W., Ma, G., & Wei, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00894-3 · Cited by 144
Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma
Chen, A., Jiang, Y., Li, Z., Wu, L., Santiago, U., Zou, H., Cai, C., Sharma, V., Guan, Y., McCarl, L. H., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci147552 · Cited by 131
Geraldo, L. H., Xu, Y., Jacob, L., Pibouin-Fragner, L., Rao, R., Maïssa, N., Verreault, M., Lemaire, N., Knosp, C. A., Lesaffre, C., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci141083 · Cited by 129
Circadian regulation of cancer cell and tumor microenvironment crosstalk
Xuan, W., Khan, F., James, C. D., Heimberger, A. B., Lesniak, M. S., & Chen, P. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.06.008 · Cited by 126
Self-citationCircadian Regulator CLOCK Drives Immunosuppression in Glioblastoma
Xuan, W., Hsu, W.-H., Khan, F., Dunterman, M., Pang, L., Wainwright, D. A., Ahmed, A. U., Heimberger, A. B., Lesniak, M. S., & Chen, P. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0559 · Cited by 126
Self-citationProtective Microglial Subset in Development, Aging, and Disease: Lessons From Transcriptomic Studies
Benmamar-Badel, A., Owens, T., & Wlodarczyk, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00430 · Cited by 124
Xu, B., Tian, L., Chen, J., Wang, J., Ma, R., Dong, W., Li, A., Zhang, J., Chiocca, E. A., Kaur, B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26003-6 · Cited by 124
Simonds, E. F., Lu, E. D., Badillo, O., Karimi, S., Liu, E. V., Tamaki, W., Rancan, C., Downey, K. M., Stultz, J., Sinha, M., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002181 · Cited by 119
Zhai, K., Huang, Z., Huang, Q., Tao, W., Fang, X., Zhang, A., Li, X., Stark, G. R., Hamilton, T. A., & Bao, S. (2021) · Nature Cancer · doi:10.1038/s43018-021-00267-9 · Cited by 117
Single-Cell RNA Sequencing with Spatial Transcriptomics of Cancer Tissues
Ahmed, R., Zaman, T., Chowdhury, F., Mraiche, F., Tariq, M., Ahmad, I. S., & Hasan, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063042 · Cited by 115
Updates in IDH-Wildtype Glioblastoma
Melhem, J. M., Detsky, J. S., Lim-Fat, M. J., & Perry, J. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01251-6 · Cited by 115
Sa, J. K., Chang, N., Lee, H. W., Cho, H. J., Ceccarelli, M., Cerulo, L., Yin, J., Kim, S. S., Caruso, F. P., Lee, M., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02140-x · Cited by 109
Self-citationChen, Z., Ross, J., & Hambardzumyan, D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902366116 · Cited by 104
Schmitt, M. J., Dramaretska, Y., Barozzi, I., Göhrig, A., Kertalli, S., Großmann, M., Naumann, H., Sánchez-Bailón, M. P., Hulsman, D., Glaß, R., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0219 · Cited by 99
Single cell RNA-seq highlights a role for a partial EMT in head and neck cancer
Puram, S. V., Parikh, A. S., & Tirosh, I. (2018) · Molecular & Cellular Oncology · doi:10.1080/23723556.2018.1448244 · Cited by 96
Li, J., Kaneda, M. M., Ma, J., Li, M., Shepard, R. M., Patel, K. S., Koga, T., Sarver, A. L., Furnari, F. B., Xu, B., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009290118 · Cited by 94
Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3
Shao, Z., Tan, Y., Shen, Q., Hou, L., Yao, B., Qin, J., Xu, P., Mao, C., Chen, L.-N., Zhang, H., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00403-4 · Cited by 86
Querfeld, C., Thompson, J. A., Taylor, M. H., DeSimone, J., Zain, J. M., Shustov, A. R., Johns, C., McCann, S. A., Lin, G. H. Y., Petrova, P. S., et al. (2021) · The Lancet Haematology · doi:10.1016/s2352-3026(21)00271-4 · Cited by 84
Ma, D., Liu, S., Lal, B., Wei, S., Wang, S., Zhan, D., Zhang, H., Lee, R. S., Gao, P., López-Bertoni, H., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3125 · Cited by 80
Kaur, S., Cicalese, K. V., Banerjee, R., & Roberts, D. D. (2020) · Antibody Therapeutics · doi:10.1093/abt/tbaa017 · Cited by 79
Antonioli, L., Novitskiy, S. V., Sachsenmeier, K. F., Fornai, M., Blandizzi, C., & Haskó, G. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.06.005 · Cited by 77
Distinction of Microglia and Macrophages in Glioblastoma: Close Relatives, Different Tasks?
Brandenburg, S., Blank, A., Bungert, A. D., & Vajkoczy, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010194 · Cited by 72
Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma
Pang, L., Khan, F., Heimberger, A. B., & Chen, P. (2022) · Trends in Cancer · doi:10.1016/j.trecan.2022.04.010 · Cited by 67
Self-citationLi, Q., Lan, X., Han, X., & Wang, J. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00520 · Cited by 64
Zhang, X., Chen, W., Fan, J., Wang, S., Xian, Z., Luan, J., Li, Y., Wang, Y., Nan, Y., Luo, M., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy041 · Cited by 63
Ott, M., Tomaszowski, K.-H., Marisetty, A., Kong, L.-Y., Wei, J., Duna, M., Blumberg, K., Ji, X., Jacob, C., Fuller, G. N., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.134386 · Cited by 61
Self-citationThe Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease
Cellai, L., Carvalho, K., Faivre, É., Deleau, A., Vieau, D., Buée, L., Blum, D. L., Mériaux, C., & Gómez‐Murcia, V. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00520 · Cited by 58
Single-cell image analysis reveals a protective role for microglia in glioblastoma
Woolf, Z., Swanson, M. E. V., Smyth, L. C. D., Mee, E. T., Schweder, P. M., Heppner, P. A., Kim, B. J. H., Turner, C. P., Oldfield, R. L., Curtis, M. A., et al. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab031 · Cited by 50
Miyazaki, T., Ishikawa, E., Matsuda, M., Sugii, N., Kohzuki, H., Akutsu, H., Sakamoto, N., Takano, S., & Matsumura, A. (2020) · Brain Tumor Pathology · doi:10.1007/s10014-020-00357-z · Cited by 47
Microglia/macrophage polarization: Fantasy or evidence of functional diversity?
Hu, X. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20963405 · Cited by 44
Vlaminck, K. D., Romão, E., Puttemans, J., Antunes, A. R. P., Kancheva, D., Scheyltjens, I., Ginderachter, J. A. V., Muyldermans, S., Devoogdt, N., Movahedi, K., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.777524 · Cited by 43
Pharmacological targeting of the tumor–immune symbiosis in glioblastoma
Pang, L., Khan, F., Dunterman, M., & Chen, P. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.04.002 · Cited by 36
Self-citationYin, W., Ping, Y., Li, F., Lv, S., Zhang, X., Li, X., Guo, Y. J., Liu, Q., Li, T., Yang, L., et al. (2022) · The Journal of Pathology · doi:10.1002/path.5984 · Cited by 34
Editorial: Brain Cancers: New Perspectives and Therapies
Roda, E., & Bottone, M. G. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.857408 · Cited by 22
Youshani, A. S., Rowlston, S., O’Leary, C., Forte, G., Parker, H., Liao, A., Telfer, B., Williams, K., Kamaly-Asl, I. D., & Bigger, B. W. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1410-y · Cited by 16
Co-dependencies in the tumor immune microenvironment
Chen, P., & Dey, P. (2022) · Oncogene · doi:10.1038/s41388-022-02406-7 · Cited by 15
Self-citationP-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression
Yeini, E., Ofek, P., Pozzi, S., Albeck, N., Ben-Shushan, D., Tiram, G., Golan, S., Kleiner, R., Sheinin, R., Dangoor, S. I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22186-0 · Cited by 9
Cited by
Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments
Xu, J., Ding, L., Mei, J., Hu, Y., Kong, X., Dai, S., Bu, T., Xiao, Q., & Ding, K. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02325-5 · Cited by 389
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Liu, Y., Zhou, F., Ali, H., Lathia, J. D., & Chen, P. (2024) · Cellular & Molecular Immunology · doi:10.1038/s41423-024-01226-x · Cited by 336
Self-citationMicroglia pack a toolbox for life
Zengeler, K. E., & Lukens, J. R. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.03.010 · Cited by 19
Althaher, A. R., & S. AL Shehadeh, R. (2024) · The Open Biomarkers Journal · doi:10.2174/0118753183367402241216115139 · Cited by 4
Metadata
- Authors
- Khan, F., Pang, L., Dunterman, M., Lesniak, M. S., Heimberger, A. B., & Chen, P.
- Venue
- Journal of Clinical Investigation
- Published
- 2023-01-03
- Volume
- 133
- Issue
- 1
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W4313427356
- Cited by
- 414
- References
- 115
- FWCI
- 36.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.